WHO Guidance on regulatory measures aimed at restricting digital marketing of breast-milk substitutes

16 November 2023. The World Health Organization (WHO) has published its Guidance on regulatory measures aimed at restricting digital marketing of breast-milk substitutes. The purpose of this guidance is to provide support to WHO Member States for developing and applying regulatory measures, by applying the Code to digital environments. The guidance provides 11 Recommendations that can be used by Member States as they work to develop and apply these regulatory measures. The BFLG-UK will make use of these recommendations in their advocacy with DHSC to strengthen regulations to protect infant feeding.